Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center

NCT00005327 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2019-07-05

No results posted yet for this study

Summary

To conduct a prospective study aimed at the early detection and treatment of cerebral vascular disease prior to irreversible brain injury in young children with sickle cell anemia (SCA).

Conditions

  • Anemia, Sickle Cell
  • Blood Disease
  • Cerebrovascular Disorders
  • Cerebrovascular Accident

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • University of Southern California

    lead OTHER

Principal Investigators

  • Darleen Powars · University of Southern California

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-04-30
Primary Completion
1998-03-31
Completion
2003-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005327 on ClinicalTrials.gov